Evidence map›Paper›PMID 40528281›Full record

Trial reportNeurorehabilitation and neural repair2025

Vestibular Rehabilitation in Multiple Sclerosis: Randomized Controlled Trial and Cost-Effectiveness Analysis Comparing Customized With Booklet Based Vestibular Rehabilitation for Vestibulopathy.

Jonathan Marsden, Rachel Dennett, Angela Gibbon, Rachel Knight Lozano, Jennifer A Freeman, Doris-Eva Bamiou, Chris Harris, Annie Hawton, Elizabeth Goodwin, Siobhan Creanor and 3 more

Abstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in Neurorehabilitation and neural repair, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Measuring health-related quality of life in multiple sclerosis: comparing the acceptability, validity and responsiveness of the EQ-5D-3L and MSIS-8D.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jonathan MarsdenSchool of Health Professions, Faculty of Health: Medicine, Dentistry and Human Science, Intercity Place, Plymouth, UK.ORCID 0000-0002-2037-4902
Rachel DennettSchool of Health Professions, Faculty of Health: Medicine, Dentistry and Human Science, Intercity Place, Plymouth, UK.ORCID 0000-0003-0400-0502
Angela GibbonSchool of Health Professions, Faculty of Health: Medicine, Dentistry and Human Science, Intercity Place, Plymouth, UK.
Rachel Knight LozanoSchool of Health Professions, Faculty of Health: Medicine, Dentistry and Human Science, Intercity Place, Plymouth, UK.
Jennifer A FreemanSchool of Health Professions, Faculty of Health: Medicine, Dentistry and Human Science, Intercity Place, Plymouth, UK.
Doris-Eva BamiouEAR Institute University College London, London, UK.
Chris HarrisSchool of Psychology, University of Plymouth, Plymouth, UK.
Annie HawtonHealth Economics Group, Faculty of Health & Life Sciences, University of Exeter, Exeter, UK.
Elizabeth GoodwinHealth Economics Group, Faculty of Health & Life Sciences, University of Exeter, Exeter, UK.ORCID 0000-0003-1351-9170
Siobhan CreanorExeter Clinical Trials Unit, Faculty of Health & Life Sciences, College House, Exeter, Devon, UK.
Lexy SorrellMedical Statistics Group and Peninsula Clinical Trials Unit, Faculty of Health: Medicine, Dentistry and Human Science, Plymouth Science Park, Plymouth, UK.
Joanne HoskingsMedical Statistics Group and Peninsula Clinical Trials Unit, Faculty of Health: Medicine, Dentistry and Human Science, Plymouth Science Park, Plymouth, UK.
Marousa PavlouAcademic Department of Physiotherapy, King's College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVestibular dysfunction occurs in 30% to 70% of cases with multiple sclerosis (MS).

objectiveTo compare the clinical and cost-effectiveness of a customized vestibular rehabilitation (VR) program with a generic booklet-based VR intervention in people with MS with clinical signs of vestibulopathy.

methodsPeople with MS and symptoms of vertigo and/or imbalance were screened for vestibulopathy (n = 73). Seventy recruited participants were randomly allocated to a 12-week generic booklet-based home program with telephone support (n = 35) or a 12-week customized VR program (n = 35, 12 face-to-face sessions and a home exercise program). The primary clinical outcome was the Dizziness Handicap Inventory (DHI) at 26 weeks post-randomization. The primary economic endpoint was quality-adjusted life-years (QALYs). Secondary outcomes included vertigo severity, balance, gait, and perceived impact of physical symptoms in MS.

resultsThere was no significant between-group difference in the DHI: mean reduction -1.76 (95% confidence interval -10.02, 6.50) at week 26 in favor of the customized group ( DISCUSSION: Impairment level improvements did not translate into functional improvements as measured by the DHI perhaps reflecting that vestibular dysfunction is one of several impairments in MS. The findings indicate the potential cost-effectiveness of the customized program. CLINICAL

trial registrationISRCTN27374299.

Indexed as

Exercise TherapyMultiple SclerosisVestibular DiseasesAdultCost-Benefit AnalysisCost-Effectiveness AnalysisDizzinessFemaleHumansMaleMiddle AgedPamphletsPostural BalanceQuality-Adjusted Life YearsTreatment Outcomebalancemultiple sclerosisrandomized controlled trialvertigovestibularvestibular rehabilitation

Identifiers

PMID40528281
PMCPMC12405695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.